There are some of the smartest people in world working on

New Post Public Reply Private Reply Replies (1) Message Board
Mo
574
There are some of the smartest people in world working on developing a treatment for COVID-19. As IPIX investors we are getting very valuable scientific testing and visibility on Brilacidin for free. It is possible that Brilacidin may play a part in COVID-19 treatment. It is also probable that the U.S. government has learned a very hard lesson in our country’s dependency on China and that this current pandemic may not be a singular event. My simplified view of COVID-19 is that it has 2 primary characteristics:

1) It is a highly contagious virus that exponentially replicates within the human body that targets the respiratory system.

2) It triggers an intense inflammatory response from our immune system that can cause a cytokine storm.

Brilacidin has proven through several FDA trials to solve #2 above which is the major cause of related COVID-19 fatalities. This feature alone could make Brilacidin a key drug for future treatments and a very valuable asset. Testing is currently taking place for #1 above which is to limit the overall viral load. If this testing is successful, Brilacidin could be a total solution for this pandemic and possibly as a baseline defense against future viral and bacterial pandemics as well as other potential biochemical weapons. Brilacidin significantly reduces the likelihood of drug resistance developing vs current antibiotic offerings on the market. This is a huge advantage in the war against this pandemic and future threats of biochemical weapons. Most importantly Brilacidin has been proven to be SAFE without the side effects of other anti-inflammatory drugs.

The current emergency treatment is to use hydroxychloroquine which hopefully addresses #1 above (viral load issue). This drug has been approved for use against malaria and lupus but has potential adverse reactions. Chloroquine Is a Zinc Ionophore (a substance which is able to transport particular ions across a lipid membrane in a cell.) There are some people that believe zinc could play a key role in a combination treatment. See the below chart for some interesting symptoms of zinc deficiency compared to COVID-19 symptoms. The other drug being used in combination with hydroxychloroquine is the antibiotic Azithromycin (Z-Pak) which is being used in the attempt to address #2 issue of intense inflammation according to Dr. Deborah Birx. Some severe side effects of Z-Pak include QT prolongation (heart muscle takes longer than normal to recharge between beats), cardiac arrhythmia and other heart related issues. “[3-12-2013] The U.S. Food and Drug Administration (FDA) is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. Patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or use of certain drugs used to treat abnormal heart rhythms, or arrhythmias.”

Additional information on cytokine storm:

With any infection, the body’s immune system responds by attacking the foreign virus or bacteria. While this immune response can rid the body of the infection, it can also sometimes cause collateral damage in the body.

This can come in the form of an intense inflammatory response, sometimes called a “cytokine storm.” The immune cells produce cytokines to fight infection, but if too many are released, it can cause problems in the body.

“A lot of [the damage in the body during COVID-19] is due to what we would call a sepsis syndrome, which is due to complex immune reactions,” Evans said. “The infection itself can generate an intense inflammatory response in the body that can affect the function of multiple organ systems.”

https://www.healthline.com/health-news/heres-...une-system

https://journals.plos.org/plosone/article?id=...ne.0109180

https://www.lewrockwell.com/2020/03/no_author...eficiency/

Zinc inhibits coronavirus RNA polymerase enzyme activity, the very methodology by which coronavirus infection is confirmed in the laboratory.

But be careful. More than 150mg/day of zinc may lead to zinc toxicity, with side effects including reduced immune function, according to the NIH.


https://s3.amazonaws.com/lrc-cdn/assets/2020/03/12324.jpg

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 166

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 157

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 178

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading
BAIC FOTON Eyes Africa for Bold Expansion Moves

Updated Category News Views 179

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 27

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 84

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 126

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
GAC Dominates with 8 Awards in Cutting-Edge Tech

Updated Category News Views 225

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...

Continue Reading
Yangtze River Culture Festival Spotlights Integration, Tradition

Updated Category News Views 0

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Continue Reading
SKYWORTH Solar's Solavita: Energizing Global Microgrids

Updated Category News Views 109

Aiming for Global Reach with Solavita Usually, when a company flings a new brand into the arena, you're looking at a whole bunch of promises and probably a fat folder of paperwork you don't want to read. But when SKYWORTH Solar dishes out Solavita as its new ace in the smart microgrid game, you reckon there's a bit of serious starch in the collar. Harnessing Worldwide...

Continue Reading

Top 5 Most Recently Viewed Articles

Aligos Therapeutics Shows Positive Progress with New Study Results

Updated Category News Views 160

Positive Developments in Aligos Therapeutics Clinical Trials Aligos Therapeutics Inc. (NASDAQ: ALGS) has recently made a splash in the news. H.C. Wainwright has reasserted a Buy rating and set a price target of $75.00 following encouraging results from the company's Phase 2a HERALD study, which explores treatments for metabolic-associated steatohepatitis (MASH). The...

Continue Reading
Grand Canal Expo Highlights: Culture, Innovation, and Future

Updated Category News Views 140

Grand Canal Culture and Tourism Expo Unveiled The 6th Grand Canal Culture and Tourism Expo was an extraordinary event that celebrated a wide array of cultural expressions and cutting-edge technologies. Organized by the Jiangsu Provincial Department of Culture and Tourism, it drew over 130,000 enthusiastic attendees and reached around 500 million viewers online from all...

Continue Reading
Eli Lilly Transitions from CVS to New Drug Benefits Provider

Updated Category News Views 292

Eli Lilly Changes Pharmacy Benefits Providers Eli Lilly & Co. (NYSE: LLY) has announced a significant shift in its drug benefit plan for employees by dropping CVS Health Inc. (NYSE: CVS) as its pharmacy benefits provider. This change is set to take effect on January 1, 2026, and signals a strategic move to enhance the quality of healthcare services offered to its...

Continue Reading
ADS-TEC Energy Optimizes Leadership with New CFO Appointment

Updated Category News Views 59

ADS-TEC Energy Announces New CFO Appointment ADS-TEC Energy recently shared exciting news about their executive leadership transition. The company, known for its cutting-edge technology in battery storage solutions and fast charging systems, is making a strategic change in its Chief Financial Officer (CFO) position. This change reflects the organization’s commitment to...

Continue Reading
Sheldon S. Lin Takes Leadership Role in Foot and Ankle Surgery

Updated Category News Views 179

Sheldon S. Lin Takes Leadership Role in Foot and Ankle Surgery Newark Orthopaedic Surgeon to Lead Growth in Foot and Ankle Specialty Foot and ankle orthopaedic surgeon Sheldon S. Lin, MD, has been appointed as the new president of the American Orthopaedic Foot & Ankle Society (AOFAS), an organization dedicated to the advancement of surgical and non-surgical practices for...

Continue Reading